Rancho BioSciences Launches OmicsHQ for AI Drug Discovery
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQ™, a comprehensive and expertly curated multi-omics data...
AI drug discovery
Advertisement
Harbour BioMed Reports Strong Preclinical Results for AI-Designed Obesity Drug LET003
CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; and SHANGHAI, China, May 18, 2026 Harbour BioMed announced promising preclinical data for LET003, its...
Isomorphic Labs Raises $2.1B for AI Drug Discovery
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
FDA Expands Drug Repurposing Initiative for Rare Diseases
WASHINGTON, May 11, 2026 The U.S. Food and Drug Administration announced a new initiative aimed at accelerating drug repurposing...
Profluent, Lilly Partner to Advance AI Gene Editing Tech
EMERYVILLE, CALIFORNIA, April 29, 2026 Profluent has announced a strategic multi-program research collaboration with Eli Lilly and Company to...
Advertisements
IGC Pharma Strengthens CALMA Trial Through Caregiver Outreach
POTOMAC, Maryland, April 28, 2026 IGC Pharma, Inc. has announced expanded caregiver engagement efforts as its Phase 2 CALMA...
Fathom Therapeutics Raises $47M to Advance AI Drug Design
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
Insilico Medicine Launches Longevity Board for AI Drug Discovery
Cambridge, Massachusetts, USA, April 21, 2026 In a transformative step for AI-driven biotechnology and longevity science, Insilico Medicine has...
Insilico Medicine Advances ISM6200 for Cancer Therapy
HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...
Decoy Therapeutics Advances AI Antiviral Pipeline Fast
CAMBRIDGE, Mass. & HOUSTON, April 9, 2026 Decoy Therapeutics, Inc. is rapidly gaining momentum as it enters a highly...
Advertisement
